The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome

Individuals with Down syndrome (DS) have shown difficulties in executive function, including the ability to implement new rules, inhibit responses, and maintain attention. Attention-deficit hyperactivity disorder (ADHD) is also related to executive function deficits, and it is not uncommon for those...

Full description

Bibliographic Details
Main Author: Mason, Gina Marie
Language:en
Published: The University of Arizona. 2010
Online Access:http://hdl.handle.net/10150/146902
id ndltd-arizona.edu-oai-arizona.openrepository.com-10150-146902
record_format oai_dc
spelling ndltd-arizona.edu-oai-arizona.openrepository.com-10150-1469022015-10-23T04:28:13Z The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome Mason, Gina Marie Individuals with Down syndrome (DS) have shown difficulties in executive function, including the ability to implement new rules, inhibit responses, and maintain attention. Attention-deficit hyperactivity disorder (ADHD) is also related to executive function deficits, and it is not uncommon for those with DS to exhibit ADHD symptoms. Studies have indicated a link between variation in two genes, catechol-o-methyltransferase (COMT) and dopamine receptor D4 (DRD4), and differences in executive ability and ADHD symptoms among typically-developing individuals. We examined whether these genes also relate to differences in executive function and ADHD symptoms within DS. Participants included 77 individuals with DS (7-40 yrs) and 50 mental-age matched controls (3-6 yrs). Participants were tested using prefrontal tasks from established assessments (e.g. CANTAB Eclipse, the Dots task), and caretakers completed questionnaires measuring ADHD symptoms. Consistent with past research, those with DS showed executive difficulties and higher inattention levels compared to controls. Within a subset of those with DS (7-20 yrs.), COMT val-val carriers displayed more omission errors on an attention task, and more impairment on parent reports of working memory. While some trends were found for DRD4, greater sample size is needed. This research adds to our knowledge of gene function under different developmental conditions, and may also lead to better pharmacological treatments for those with DS. 2010-05 text Electronic Thesis http://hdl.handle.net/10150/146902 en Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. The University of Arizona.
collection NDLTD
language en
sources NDLTD
description Individuals with Down syndrome (DS) have shown difficulties in executive function, including the ability to implement new rules, inhibit responses, and maintain attention. Attention-deficit hyperactivity disorder (ADHD) is also related to executive function deficits, and it is not uncommon for those with DS to exhibit ADHD symptoms. Studies have indicated a link between variation in two genes, catechol-o-methyltransferase (COMT) and dopamine receptor D4 (DRD4), and differences in executive ability and ADHD symptoms among typically-developing individuals. We examined whether these genes also relate to differences in executive function and ADHD symptoms within DS. Participants included 77 individuals with DS (7-40 yrs) and 50 mental-age matched controls (3-6 yrs). Participants were tested using prefrontal tasks from established assessments (e.g. CANTAB Eclipse, the Dots task), and caretakers completed questionnaires measuring ADHD symptoms. Consistent with past research, those with DS showed executive difficulties and higher inattention levels compared to controls. Within a subset of those with DS (7-20 yrs.), COMT val-val carriers displayed more omission errors on an attention task, and more impairment on parent reports of working memory. While some trends were found for DRD4, greater sample size is needed. This research adds to our knowledge of gene function under different developmental conditions, and may also lead to better pharmacological treatments for those with DS.
author Mason, Gina Marie
spellingShingle Mason, Gina Marie
The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome
author_facet Mason, Gina Marie
author_sort Mason, Gina Marie
title The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome
title_short The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome
title_full The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome
title_fullStr The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome
title_full_unstemmed The Role of Catechol-o-Methyltransferase and Dopamine Receptor D4 in ADHD Symptom Variation Among Individuals with Down Syndrome
title_sort role of catechol-o-methyltransferase and dopamine receptor d4 in adhd symptom variation among individuals with down syndrome
publisher The University of Arizona.
publishDate 2010
url http://hdl.handle.net/10150/146902
work_keys_str_mv AT masonginamarie theroleofcatecholomethyltransferaseanddopaminereceptord4inadhdsymptomvariationamongindividualswithdownsyndrome
AT masonginamarie roleofcatecholomethyltransferaseanddopaminereceptord4inadhdsymptomvariationamongindividualswithdownsyndrome
_version_ 1718097113889374208